Which patients with chronic heart failure should be referred for CRT-D implantation? Practical implications of current clinical research

Polskie Archiwum Medycyny Wewnetrznej

Volumn 120, Issue 3, 2010, Pages 95-102

  Zareba, Wojciech ^a   Zareba, Karolina M ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac resynchronization therapy; Cardiomyopathy; Heart failure; Implantable cardioverter defibrillator

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE COURSE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; MORTALITY; REVIEW; TREATMENT INDICATION;

EID: 77951045283     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: 10.20452/pamw.897     Document Type: Review

References (25)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart Disease and Stroke Statistics - 2010 Update. A report from the American Heart Association. Circulation. 2009 Dec 17. [Epub ahead of print].
2. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003; 348: 2007-2018.
3. McMurray JJ. Clinical practice. Systolic heart failure. N Engl J Med. 2010; 362:228-238.
4. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346:877-883. (Pubitemid 34984635)
5. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352: 225-237.
6. US Patent 4,928,688: Morton Mower and Mieczyslaw Mirowski. Method and apparatus for treating hemodynamic disfunction. May 29, 1990.
7. Blanc JJ, Etienne Y, Gilard M, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation. 1997; 96: 3273-3277. (Pubitemid 27513393)
8. Auricchio A, Stellbrink C, Sack S, et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol. 2002; 39: 2026-2033. (Pubitemid 34628286)
9. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J. 2002; 23: 1780-1787. (Pubitemid 35334271)
10. Jeevanantham V, Dauben JP, Zareba W. Cardiac resynchronization therapy in heart failure patients: an update. Cardiol J. 2009; 16: 197-209.
11. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001; 344: 873-880. (Pubitemid 32224395)
12. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002; 346: 1845-1853. (Pubitemid 34603028)
13. Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol. 2003; 42: 1454-1459. (Pubitemid 37267289)
14. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003; 289: 2685-2694.
15. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004; 350: 2140-2150. (Pubitemid 38637994)
16. Cleland JGF, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005; 352: 1539-1549. (Pubitemid 40517094)
17. Vardas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J. 2007; 28: 2256-2295.
18. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008; 117: e350-408.
19. Beshai JF, Grimm RA, Nagueh SF, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007; 357: 2461-2671.
20. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008; 52: 1834-1843.
21. Daubert C, Gold MR, Abraham WT, et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol 2009; 54: 1837-1846.
22. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009; 361: 1329-1338.
23. Byrne MJ, Helm RH, Daya S, et al. Diminished left ventricular dyssynchrony and impact of resynchronization in failing hearts with right versus left bundle branch block. J Am Coll Cardiol. 2007; 50: 1484-1490. (Pubitemid 47494595)
24. Adelstein EC, Saba S. Usefulness of baseline electrocardiographic QRS complex pattern to predict response to cardiac resynchronization. Am J Cardiol. 2009; 103: 238-242.
25. Wokhlu A, Rea RF, Asirvatham SJ, et al. Upgrade and de novo cardiac resynchronization therapy: impact of paced or intrinsic QRS morphology on outcomes and survival. Heart Rhythm. 2009; 6: 1439-1447.